Therapeutic Targeting of Complement C5a Receptors in HuntingtonÍs Disease [ 2011 - 2013 ]

Research Grant

Researchers: A/Pr Trent Woodruff (Principal investigator) ,  A/Pr John O'Sullivan ,  A/Pr Peter Noakes ,  Dr Estifanos Ghebremedhin ,  Prof Stephen Taylor

Brief description HuntingtonÍs disease is a genetic neurodegenerative condition leading to progressive cognitive and motor deficits and eventual death. This research aims to explore the role of immune and inflammatory pathways in the progression of disease in patients suffering HuntingtonÍs disease, as well as in an animal model of this condition. By exploring these immune and inflammatory pathways, we aim to identify novel therapeutic targets to treat HuntingtonÍs disease.

Funding Amount $AUD 468,312.58

Funding Scheme Project Grants

Notes Standard Project Grant